Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease (Q80356660)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 2004

Language	Label	Description	Also known as
English	Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease	scientific article published on 01 July 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

based on heuristic

inferred from title

clear cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Chih-Ming Ho

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Yun-Ju Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tze-Chien Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Shih-Hung Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Fu-Shing Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Chan-Chao Chang Chien

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mu-Hsien Yu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tsui-Lien Mao

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tao-Yeuan Wang

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Chang-Yao Hsieh

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

94

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

197-203

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Clear cell carcinoma of the ovary: A clinicopathologic study with review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Survival probability in ovarian clear cell adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Endometrioid and clear cell carcinoma of the ovary. Factors affecting survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YGYNO.2004.04.004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80356660&oldid=1757995796"